
A healthcare worker holds vials containing doses of the Johnson & Johnson Covid-19 vaccine on February 18, 2021 in South Africa. (Photo: Phill Magakoe/AFP via Getty Images)
To donate by check, phone, or other method, see our More Ways to Give page.
A healthcare worker holds vials containing doses of the Johnson & Johnson Covid-19 vaccine on February 18, 2021 in South Africa. (Photo: Phill Magakoe/AFP via Getty Images)
The European Union has agreed to return to Africa millions of Johnson & Johnson coronavirus vaccine doses that were shipped out of the continent under a contract arrangement that drew widespread backlash from vaccine equity campaigners and African officials.
As the Wall Street Journal reported Thursday, the South Africa-based pharmaceutical giant Aspen "has a contract with J&J to fill into vials and package the U.S. company's vaccine, with some 40% of its production slated for export to Europe through September and the rest going to African countries."
When the details of the contract first emerged last month, Fatima Hassan of the South Africa-based Health Justice Initiative called the agreement "the sickening result of the free market in a pandemic--while Africa waits for supplies and gets a drip feed, more vaccine stock is diverted to Europe."
But Strive Masiyiwa, head of the African Union's Vaccine Acquisition Task Team, said Thursday that the "arrangement has been suspended." Masiyiwa said less than 20 million doses were exported to the E.U. under the deal.
"All the vaccines from this facility are now under the control of the South African government," he added.
\u201cYup, HALTED, because of activist pressure and excellent reporting from New York Times that blew this wide open.\n\nWe warned for months abt missing vaccines. So glad that we managed to halt this. \n\nTransparency, not secrecy.\u201d— Fatima Hassan @FatimaHassan@mastodon.social (@Fatima Hassan @FatimaHassan@mastodon.social) 1630619040
The People's Vaccine Alliance, a coalition of more than 70 international public health and human rights organizations, called the suspension of the agreement "a step in the right direction" and said that "African manufacturers should be allowed to produce for Africans."
"Activism works! We can and must overcome greedy pharma and selfish rich governments' business as usual," the coalition tweeted. "We need a people's vaccine."
According to the latest data, just 11% of South Africa's population--and less than 3% of the total population of the African continent--has been fully vaccinated. By contrast, around 70% of adults in the E.U. have been fully inoculated against Covid-19.
"In Africa, the issue is vaccine supply," Masiyiwa said Thursday. "Even if there are loud noises about vaccine hesitancy--and we will not dismiss it--but let's get to 60%, OK, and then we worry about the 40%."
"But if 60% of our population right now are happy to take the vaccine," he added, "let's give it to them."
Dear Common Dreams reader, The U.S. is on a fast track to authoritarianism like nothing I've ever seen. Meanwhile, corporate news outlets are utterly capitulating to Trump, twisting their coverage to avoid drawing his ire while lining up to stuff cash in his pockets. That's why I believe that Common Dreams is doing the best and most consequential reporting that we've ever done. Our small but mighty team is a progressive reporting powerhouse, covering the news every day that the corporate media never will. Our mission has always been simple: To inform. To inspire. And to ignite change for the common good. Now here's the key piece that I want all our readers to understand: None of this would be possible without your financial support. That's not just some fundraising cliche. It's the absolute and literal truth. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. The final deadline for our crucial Summer Campaign fundraising drive is just days away, and we’re falling short of our must-hit goal. Will you donate now to help power the nonprofit, independent reporting of Common Dreams? Thank you for being a vital member of our community. Together, we can keep independent journalism alive when it’s needed most. - Craig Brown, Co-founder |
The European Union has agreed to return to Africa millions of Johnson & Johnson coronavirus vaccine doses that were shipped out of the continent under a contract arrangement that drew widespread backlash from vaccine equity campaigners and African officials.
As the Wall Street Journal reported Thursday, the South Africa-based pharmaceutical giant Aspen "has a contract with J&J to fill into vials and package the U.S. company's vaccine, with some 40% of its production slated for export to Europe through September and the rest going to African countries."
When the details of the contract first emerged last month, Fatima Hassan of the South Africa-based Health Justice Initiative called the agreement "the sickening result of the free market in a pandemic--while Africa waits for supplies and gets a drip feed, more vaccine stock is diverted to Europe."
But Strive Masiyiwa, head of the African Union's Vaccine Acquisition Task Team, said Thursday that the "arrangement has been suspended." Masiyiwa said less than 20 million doses were exported to the E.U. under the deal.
"All the vaccines from this facility are now under the control of the South African government," he added.
\u201cYup, HALTED, because of activist pressure and excellent reporting from New York Times that blew this wide open.\n\nWe warned for months abt missing vaccines. So glad that we managed to halt this. \n\nTransparency, not secrecy.\u201d— Fatima Hassan @FatimaHassan@mastodon.social (@Fatima Hassan @FatimaHassan@mastodon.social) 1630619040
The People's Vaccine Alliance, a coalition of more than 70 international public health and human rights organizations, called the suspension of the agreement "a step in the right direction" and said that "African manufacturers should be allowed to produce for Africans."
"Activism works! We can and must overcome greedy pharma and selfish rich governments' business as usual," the coalition tweeted. "We need a people's vaccine."
According to the latest data, just 11% of South Africa's population--and less than 3% of the total population of the African continent--has been fully vaccinated. By contrast, around 70% of adults in the E.U. have been fully inoculated against Covid-19.
"In Africa, the issue is vaccine supply," Masiyiwa said Thursday. "Even if there are loud noises about vaccine hesitancy--and we will not dismiss it--but let's get to 60%, OK, and then we worry about the 40%."
"But if 60% of our population right now are happy to take the vaccine," he added, "let's give it to them."
The European Union has agreed to return to Africa millions of Johnson & Johnson coronavirus vaccine doses that were shipped out of the continent under a contract arrangement that drew widespread backlash from vaccine equity campaigners and African officials.
As the Wall Street Journal reported Thursday, the South Africa-based pharmaceutical giant Aspen "has a contract with J&J to fill into vials and package the U.S. company's vaccine, with some 40% of its production slated for export to Europe through September and the rest going to African countries."
When the details of the contract first emerged last month, Fatima Hassan of the South Africa-based Health Justice Initiative called the agreement "the sickening result of the free market in a pandemic--while Africa waits for supplies and gets a drip feed, more vaccine stock is diverted to Europe."
But Strive Masiyiwa, head of the African Union's Vaccine Acquisition Task Team, said Thursday that the "arrangement has been suspended." Masiyiwa said less than 20 million doses were exported to the E.U. under the deal.
"All the vaccines from this facility are now under the control of the South African government," he added.
\u201cYup, HALTED, because of activist pressure and excellent reporting from New York Times that blew this wide open.\n\nWe warned for months abt missing vaccines. So glad that we managed to halt this. \n\nTransparency, not secrecy.\u201d— Fatima Hassan @FatimaHassan@mastodon.social (@Fatima Hassan @FatimaHassan@mastodon.social) 1630619040
The People's Vaccine Alliance, a coalition of more than 70 international public health and human rights organizations, called the suspension of the agreement "a step in the right direction" and said that "African manufacturers should be allowed to produce for Africans."
"Activism works! We can and must overcome greedy pharma and selfish rich governments' business as usual," the coalition tweeted. "We need a people's vaccine."
According to the latest data, just 11% of South Africa's population--and less than 3% of the total population of the African continent--has been fully vaccinated. By contrast, around 70% of adults in the E.U. have been fully inoculated against Covid-19.
"In Africa, the issue is vaccine supply," Masiyiwa said Thursday. "Even if there are loud noises about vaccine hesitancy--and we will not dismiss it--but let's get to 60%, OK, and then we worry about the 40%."
"But if 60% of our population right now are happy to take the vaccine," he added, "let's give it to them."